'Super' aspirin and clot buster drug may help heart attack victims avoid surgery

Dallas, June 1 -- Two clot-thinning drugs may be better than one for treating heart attacks, according to results of new study that appears in today's Circulation:Journal of the American Heart Association.

One drug, called a thrombolytic, dissolves blood clots. The second drug, a platelet IIb/IIIa receptor blocker, keeps platelets from clumping and forming the blood clots that can obstruct blood flow and thereby trigger a heart attack or stroke. The platelet blockers, sometimes called "super aspirin" are more potent than aspirin. They are also administered through an intravenous drip or infusion.

According to lead investigator of the study, Elliott Antman, M.D., director of the Coronary Care Unit at Brigham and Women's Hospital, Boston, "The trial tested the hypothesis that the platelet blocker is a potent and safe addition to thrombolytic regimens."

Results of the new study, called the TIMI 14 trial, are so impressive, that researchers say that many individuals with heart attacks who otherwise would require angioplasty or bypass surgery to restore blood flow to the heart may be treated instead with both drugs. Angioplasty involves using a narrow tube with a deflated balloon on its tip that is passed into the narrowed part of the artery. When the balloon is inflated, the blockages or blood clots are pushed aside, allowing blood to flow through. Bypass surgery is an operation that uses blood vessels "borrowed" from another part of the body to go around clogged coronary arteries to reestablish blood flow to the heart.

According to J. Ward Kennedy, M.D., who wrote an accompanying editorial, the investigators have "made a major contribution to the management of acute myocardial infarctions (heart attacks)" -- and identified a therapy, which will likely prove to be equivalent or superior to opening blood vessels with medical procedures such as angioplasty.

The study included 888 individuals who had suffered a heart attack. Patients were t

Contact: Carole Bullock
American Heart Association

Page: 1 2

Related medicine news :

1. Many postmenopausal women with cardiovascular disease dont use lifesaving aspirin therapy
2. Survivors who stop taking aspirin increase risk of another stroke
3. Study says 43% of US adults at risk of heart disease are not utilizing aspirin therapy
4. Low-dose aspirin and stomach ulcer medications better for heart patients with GI complications
5. Statins and aspirin may protect against severe vision loss in elderly
6. One in five asthmatics are highly sensitive to aspirin
7. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix
8. Study supports role of aspirin in reducing risk of colorectal cancer
9. Mt. Sinai researchers report that aspirin reduces risk of first heart attack by one-third
10. Ibuprofen could reduce cardioprotective effect of aspirin
11. Totality of evidence shows aspirin reduces risk of a first heart attack by one-third

Post Your Comments:

(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named ... joined AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair ... interim chair since October and is also part of the pathology faculty at Drexel ...
(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 ... published research on the health benefits of coconut oil in the 7 November 2019 ... Effects on the Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. ...
(Date:12/5/2019)... ... 2019 , ... It’s been an impactful year for ... embrace, achieve, and maintain a healthy lifestyle to giving generously to communities in ... of impacting world health, so it’s gratifying to look back on the many ...
(Date:12/4/2019)... ... 2019 , ... Healthcare Real Estate Insights™ magazine has announced ... to recognizing excellence in the areas of healthcare real estate (HRE) development and ... during the GlobeSt Healthcare Conference today in Scottsdale, Ariz. , The awards are ...
(Date:12/2/2019)... ... December 02, 2019 , ... TrialScope, the global leader ... the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, ... educate and inform patients, caregivers, the public, patient advocacy groups and healthcare professionals ...
Breaking Medicine News(10 mins):
(Date:12/5/2019)... ... December 05, 2019 , ... Cognosante is ... Sector Partner Program; a designation that will accelerate digital transformation for public ... partners that offer solutions and proven experience delivering on government, education and ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... healthcare professionals with minimally invasive technologies to treat chronic pain in soft and ... the Tenex Health TX® technology. , Dr. Bernard Morrey, Chief Medical ...
(Date:12/2/2019)... ... December 02, 2019 , ... Data integration has been a pharma industry buzzword ... and external data sources, staff are still working in silos and are not aware ... take six weeks or more, and nearly one-third of qualified investigators may be overlooked. ...
Breaking Medicine Technology:
Cached News: